Polar Capital Global Healthcare Trust plc ("the Company")
Legal Entity Identifier: 549300YV7J2TWLE7PV84
10 November 2023
Transactions in a Closed Period
The Company confirms that:
· all inside information (as defined in the Market Abuse Regulation) which the Directors and the Company may have, in the period leading up to the announcement of results in respect of the year ended 30 September 2023 has previously been published or notified via a regulatory information service; and
· the Company's net asset value per share is calculated and announced via a regulatory information service daily.
The Company is therefore not prohibited from dealing in its own securities during the closed period, (as defined by the Market Abuse Regulation) which will end on expected publication of the Company's annual results on or around 13 December 2023.
The Company further confirms that:
if, in the period leading up to the announcement of the annual results, the Directors of the Company come into possession of any inside information, this will be notified to a regulatory information service before any such dealings are undertaken.
For further information, please contact:
|
Tracey Lago, FCG Director Polar Capital Secretarial Services Corporate Secretary
|
+44 (0)20 7227 2700 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
